Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Affrique"


8 mentions found


Bloomberg | Getty ImagesThe CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime. Antoine de Saint-Affrique said that surging demand for drugs like Wegovy and Mounjaro would only increase consumer appetite for more nutritional products. "We see ourselves as extremely complementary to GLP-1s," de Saint-Affrique told CNBC's Charlotte Reed Wednesday. GLP-1s, or glucagon-like peptide 1 agonists, are the underlying class of drugs in weight loss injections such as Wegovy and Mounjaro. watch nowThe rapid rise of such drugs has prompted concern among food makers, who fear falling sales as consumer appetite wanes.
Persons: Antoine de Saint, Affrique, Mounjaro, CNBC's Charlotte Reed, de, Kepler Cheuvreux Organizations: Danone SA, Bloomberg, Getty, Danone, Novo Nordisk
Danone products complementary to GLP-1s, says CEO
  + stars: | 2024-04-04 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDanone products complementary to GLP-1s, says CEOAntoine de Saint-Affrique, CEO at Danone, discusses the impact of anti-obesity drugs on the business.
Persons: Antoine de Saint Organizations: Danone
Danone CEO discusses partnership with the 2024 Paris Olympics
  + stars: | 2024-04-04 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDanone CEO discusses partnership with the 2024 Paris OlympicsAntoine de Saint-Affrique, CEO of the French food company, discusses the company's partnership with the 2024 Paris Olympics.
Persons: Antoine de Saint Organizations: Danone
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDanone CEO: Our dependence on nature means sustainability is at our coreAntoine de Saint-Affrique, CEO of Danone, discusses what the company is doing to deal with the cost-of-living-crisis and climate change, among other things.
Persons: Antoine de Saint Organizations: Danone
Dairy products of French food group Danone are seen in a supermarket in Nice, France, January 9, 2023. REUTERS/Eric Gaillard/File photo Acquire Licensing RightsPARIS, Oct 26 (Reuters) - French food group Danone (DANO.PA) raised its 2023 revenue growth forecast after its third-quarter sales beat analysts' estimates, as higher prices helped offset lower volumes. Overall, Danone increased its prices by 6.6% during the quarter while sales volume declined 0.3%, a sequential improvement led by Essential Dairy and Plant-based. Danone, like its rivals Nestle (NESN.S) and Unilever (ULVR.L), has increased prices to cope with higher commodities and supply chain costs. Last week, Nestle (NESN.S) posted lower-than-expected nine-month sales growth as higher product prices made shoppers balk.
Persons: Eric Gaillard, Antoine de Saint, Affrique, Dominique Vidalon, Sudip Kar, Gupta, Jacqueline Wong Organizations: Danone, REUTERS, Rights, Evian, Essential Dairy, Nestle, Unilever, Investors, Thomson Locations: Nice, France, Europe
PARIS, April 26 (Reuters) - Danone (DANO.PA) raised its 2023 sales growth outlook after it reported higher-than-expected first-quarter revenue on Wednesday, as the world's largest yoghurt maker was able to raise prices in the face of high raw materials and energy costs. Danone, maker of Activia yoghurt, Evian water and Aptamil infant milk said it expected like-for-like 2023 sales growth of between 4% and 6%, having previously forecast 3-5% growth. Danone said sales rose 10.5% like-for-like to 6.96 billion euros in the first quarter, beating expectations for 7.3% growth in a company-compiled consensus of 18 analysts. Danone, like its rivals Nestle (NESN.S) and Unilever (ULVR.L), has increased prices to cope with surging commodities and supply chain costs but faces a challenge when it comes to the extent of price hikes before even affluent shoppers decide enough is enough. Danone increased its prices by 10.3% during the quarter while sales volume remained positive, up 0.2%.
PARIS, Feb 22 (Reuters) - Danone (DANO.PA) like-for-like quarterly sales growth topped estimates on Wednesday on the back of higher prices amid soaring raw materials and energy costs which still weighed down its full-year operating margin. The world's largest yoghurt maker's 2023 forecast was in line with its mid-term like-for-like sales growth target of 3% to 5%, with a moderate improvement in recurring operating margin. The owner of Activia yoghurt and Evian bottled water reported like-for-like sales growth of 7.8% for 2022, near the top end of its 7% to 8% sales growth forecast. Danone reported fourth-quarter sales growth of 7%, beating market expectations of 6.2%, helped by growth across Essential Dairy and Plant-based, Specialised Nutrition and Waters segments. "Building on 2022 momentum, we are entering 2023 with renewed ambition and confidence in our strategy," CEO Antoine de Saint-Affrique said in a statement.
PARIS, Oct 27 (Reuters) - French food group Danone (DANO.PA) on Thursday raised its 2022 revenue growth forecast after its third-quarter sales beat analysts' estimates as the firm was able to raise prices to counter soaring costs. Danone posted a 9.5% rise in third-quarter like-for-like sales to 7.334 billion euros ($7.35 billion), beating analysts' expectations for a 6.9% rise in a poll compiled by the company. This also marked a sequential acceleration from 7.7% sales growth achieved in the second quarter and reflected strength in all the group's businesses, notably in baby food in China and in bottled waters. Price increases contributed 10.9% to third-quarter revenue growth. Rival Unilever Plc (ULVR.L) also on Thursday raised its full-year sales forecast as it lifted prices to counter costs.
Total: 8